Abstract

Numerous imaging modalities may be used for the staging of women with advanced breast cancer. Although bone scintigraphy and multiplanar-CT are the most frequently used tests, others including PET, MRI and hybrid scans are also utilised, with no specific recommendations of which test should be preferentially used. We review the evidence behind the imaging modalities that characterise metastases in breast cancer and to update the evidence on comparative imaging accuracy.

Details

Title
Imaging diagnosis of metastatic breast cancer
Author
Pesapane Filippo 1   VIAFID ORCID Logo  ; Downey, Kate 2 ; Rotili Anna 1 ; Cassano Enrico 1 ; Dow-Mu, Koh 3 

1  IEO - European Institute of Oncology IRCCS, Breast Imaging Division, Milano, Italy (GRID:grid.15667.33) (ISNI:0000 0004 1757 0843) 
2  Royal Marsden Hospital, Department of Breast Radiology, Sutton, UK (GRID:grid.424926.f) (ISNI:0000 0004 0417 0461) 
3  The Institute of Cancer Research, Cancer Research UK Cancer Imaging Centre, Sutton, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1271 4623); Royal Marsden Hospital, Department of Radiology, Sutton, UK (GRID:grid.424926.f) (ISNI:0000 0004 0417 0461) 
Publication year
2020
Publication date
Dec 2020
Publisher
Springer Nature B.V.
e-ISSN
18694101
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s13244-020-00885-4
ProQuest document ID
2413799185
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.